Mumbai: Sanofi India Limited has announced its financial results for the quarter ended June 30, 2025.The Company recorded a 9 ...

Funds should be able to invest more in promising local innovations, keeping IP in Australia and boosting productivity while ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

Foreign firms showed mixed reactions to the decision, with some willing to offload a 5% stake while others were not ...

Q1 2025 Earnings Call Transcript August 1, 2025 Operator: Welcome to the conference call regarding L’Oréal’s 2025 Half Year ...

The French pharmaceutical company claims that Sarclisa-VRD showed great improvement in the minimum residual disease (MRD) ...

He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...

FDA granted Orphan Drug Designation to Sanofi’s SAR446523, a monoclonal antibody targeting GPRC5D, for relapsed/refractory ...

BENGALURU] European stocks logged their biggest one-day drop in over three months on Friday (Aug 1), at the end of a busy ...

Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.

U.S. sales of Eylea HD and Eylea, treatments for eye conditions like wet age-related macular degeneration, decrease 25% in ...

The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs.